Letters to the Editor

STAT1 activation in association with JAK2 exon 12 mutations

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain
Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy
Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK
University Hospital of Ulm, Department of Internal Medicine III, Germany
Institut Bergonie, Department of Hematology, Bordeaux, France
Laboratoire d’Hematologie, CHU de Bordeaux and Laboratorie Hematopoiese Leucemique et Cibles Thérapeutiques, INSERM U 1035, Universite Bordeaux Segalen, Bordeaux, France
University of Bordeaux, Etablissement Français du Sang, France
University Hospital of Ulm, Department of Internal Medicine III, Germany
Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy
Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, UK;Department of Haematology, University of Cambridge, Cambridge, UK
Vol. 101 No. 1 (2016): January, 2016 https://doi.org/10.3324/haematol.2015.128546